Evidence map›Paper›PMID 32867359›Full record

ArticleInternational journal of molecular sciences2020

TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.

Chien-Lin Lu, Chun-Hou Liao, Kuo-Cheng Lu, Ming-Chieh Ma

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Microbiota-gut-kidney axis in health and renal disease.International journal of biological sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chien-Lin LuDivision of Nephrology, Department of Medicine, Fu Jen Catholic University Hospital, New Taipei City 24205, Taiwan.ORCID 0000-0002-9452-5179
Chun-Hou LiaoSchool of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Kuo-Cheng LuDivision of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Ming-Chieh MaSchool of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Fu Jen Catholic University · TWTaipei Tzu Chi Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indoxyl sulfate (IS) is accumulated during severe renal insufficiency and known for its nephrotoxic properties. Transient receptor potential vanilloid 1 (TRPV1) is present in the kidney and acts as a renal sensor. However, the mechanism underlying IS-mediated renal tubular damage in view of TRPV1 is lacking. Here, we demonstrated that TRPV1 was expressed in tubular cells of Lilly Laboratories cell-porcine kidney 1 (LLC-PK

Indexed as

AnimalsArachidonate 12-LipoxygenaseCaffeic AcidsCell LineCell SurvivalDogsDose-Response Relationship, DrugDown-RegulationFlavanonesHydroxyeicosatetraenoic AcidsIndicanKidney TubulesMadin Darby Canine Kidney CellsModels, BiologicalReceptors, Aryl HydrocarbonSwineArachidonate 12-LipoxygenasebaicaleinCaffeic Acidscinnamyl-3,4-dihydroxycyanocinnamateFlavanonesHydroxyeicosatetraenoic AcidsIndicanReceptors, Aryl HydrocarbonTRPV Cation Channels12(S)-hydroxyeicosatetraenoic acidarachidonate 12-lipoxygenasearyl hydrocarbon receptorindoxyl sulfaterenal tubular damagetransient receptor potential vanilloid 1

Identifiers

PMID32867359
PMCPMC7503230
OpenAlexW3080615393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.